NM_002667.5:c.*397T>G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002667.5(PLN):​c.*397T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.474 in 233,892 control chromosomes in the GnomAD database, including 27,328 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.46 ( 16895 hom., cov: 31)
Exomes 𝑓: 0.49 ( 10433 hom. )

Consequence

PLN
NM_002667.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.604

Publications

9 publications found
Variant links:
Genes affected
PLN (HGNC:9080): (phospholamban) The protein encoded by this gene is found as a pentamer and is a major substrate for the cAMP-dependent protein kinase in cardiac muscle. The encoded protein is an inhibitor of cardiac muscle sarcoplasmic reticulum Ca(2+)-ATPase in the unphosphorylated state, but inhibition is relieved upon phosphorylation of the protein. The subsequent activation of the Ca(2+) pump leads to enhanced muscle relaxation rates, thereby contributing to the inotropic response elicited in heart by beta-agonists. The encoded protein is a key regulator of cardiac diastolic function. Mutations in this gene are a cause of inherited human dilated cardiomyopathy with refractory congestive heart failure, and also familial hypertrophic cardiomyopathy. [provided by RefSeq, Apr 2016]
CEP85L (HGNC:21638): (centrosomal protein 85 like) The protein encoded by this gene was identified as a breast cancer antigen. Nothing more is known of its function at this time. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]
CEP85L Gene-Disease associations (from GenCC):
  • lissencephaly 10
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • lissencephaly due to LIS1 mutation
    Inheritance: AD Classification: STRONG Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 6-118559477-T-G is Benign according to our data. Variant chr6-118559477-T-G is described in ClinVar as Benign. ClinVar VariationId is 355141.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.535 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLNNM_002667.5 linkc.*397T>G 3_prime_UTR_variant Exon 2 of 2 ENST00000357525.6 NP_002658.1
CEP85LNM_001042475.3 linkc.1020+6052A>C intron_variant Intron 3 of 12 ENST00000368491.8 NP_001035940.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLNENST00000357525.6 linkc.*397T>G 3_prime_UTR_variant Exon 2 of 2 1 NM_002667.5 ENSP00000350132.5
CEP85LENST00000368491.8 linkc.1020+6052A>C intron_variant Intron 3 of 12 1 NM_001042475.3 ENSP00000357477.3

Frequencies

GnomAD3 genomes
AF:
0.465
AC:
70541
AN:
151834
Hom.:
16897
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.393
Gnomad AMI
AF:
0.409
Gnomad AMR
AF:
0.344
Gnomad ASJ
AF:
0.446
Gnomad EAS
AF:
0.302
Gnomad SAS
AF:
0.486
Gnomad FIN
AF:
0.521
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.540
Gnomad OTH
AF:
0.437
GnomAD4 exome
AF:
0.493
AC:
40420
AN:
81940
Hom.:
10433
Cov.:
0
AF XY:
0.485
AC XY:
20631
AN XY:
42552
show subpopulations
African (AFR)
AF:
0.356
AC:
504
AN:
1414
American (AMR)
AF:
0.299
AC:
1135
AN:
3796
Ashkenazi Jewish (ASJ)
AF:
0.418
AC:
671
AN:
1604
East Asian (EAS)
AF:
0.272
AC:
964
AN:
3542
South Asian (SAS)
AF:
0.470
AC:
5011
AN:
10666
European-Finnish (FIN)
AF:
0.523
AC:
9169
AN:
17522
Middle Eastern (MID)
AF:
0.479
AC:
91
AN:
190
European-Non Finnish (NFE)
AF:
0.531
AC:
21111
AN:
39722
Other (OTH)
AF:
0.506
AC:
1764
AN:
3484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1009
2018
3027
4036
5045
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.464
AC:
70560
AN:
151952
Hom.:
16895
Cov.:
31
AF XY:
0.460
AC XY:
34137
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.392
AC:
16255
AN:
41444
American (AMR)
AF:
0.343
AC:
5234
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.446
AC:
1548
AN:
3470
East Asian (EAS)
AF:
0.302
AC:
1565
AN:
5174
South Asian (SAS)
AF:
0.486
AC:
2341
AN:
4816
European-Finnish (FIN)
AF:
0.521
AC:
5492
AN:
10544
Middle Eastern (MID)
AF:
0.571
AC:
168
AN:
294
European-Non Finnish (NFE)
AF:
0.540
AC:
36666
AN:
67922
Other (OTH)
AF:
0.436
AC:
920
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1895
3790
5686
7581
9476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.474
Hom.:
6081
Bravo
AF:
0.445
Asia WGS
AF:
0.372
AC:
1286
AN:
3460

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Dilated cardiomyopathy 1P Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.4
DANN
Benign
0.58
PhyloP100
0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12198461; hg19: chr6-118880640; COSMIC: COSV62645809; API